ANDLAUER HEALTHCARE GROUP IN (AND.CA) Stock Fundamental Analysis
Canada - TSX:AND - CA0342231077 - Common Stock
52.7 CAD
-0.07 (-0.13%)
Overall AND gets a fundamental rating of 6 out of 10. We evaluated AND against 15 industry peers in the Health Care Providers & Services industry. AND scores excellent points on both the profitability and health parts. This is a solid base for a good stock. AND is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year AND was profitable.
AND had a positive operating cash flow in the past year.
AND had positive earnings in each of the past 5 years.
In the past 5 years AND always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of AND (9.81%) is better than 80.00% of its industry peers.
With an excellent Return On Equity value of 15.35%, AND belongs to the best of the industry, outperforming 86.67% of the companies in the same industry.
AND's Return On Invested Capital of 11.76% is amongst the best of the industry. AND outperforms 86.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AND is above the industry average of 7.83%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.81% | ||
| ROE | 15.35% | ||
| ROIC | 11.76% |
ROA(3y)9.88%
ROA(5y)11.71%
ROE(3y)15.44%
ROE(5y)22.37%
ROIC(3y)11.97%
ROIC(5y)12.76%
1.3 Margins
Looking at the Profit Margin, with a value of 10.37%, AND belongs to the top of the industry, outperforming 86.67% of the companies in the same industry.
AND's Profit Margin has been stable in the last couple of years.
AND has a Operating Margin of 13.99%. This is amongst the best in the industry. AND outperforms 86.67% of its industry peers.
AND's Operating Margin has been stable in the last couple of years.
AND's Gross Margin of 33.85% is on the low side compared to the rest of the industry. AND is outperformed by 60.00% of its industry peers.
AND's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.99% | ||
| PM (TTM) | 10.37% | ||
| GM | 33.85% |
OM growth 3Y-4.81%
OM growth 5Y-1.42%
PM growth 3Y-21.44%
PM growth 5Y-0.72%
GM growth 3Y-14.76%
GM growth 5Y-10.42%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AND is creating some value.
Compared to 1 year ago, AND has less shares outstanding
Compared to 5 years ago, AND has more shares outstanding
Compared to 1 year ago, AND has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 5.91 indicates that AND is not in any danger for bankruptcy at the moment.
AND has a better Altman-Z score (5.91) than 93.33% of its industry peers.
AND has a debt to FCF ratio of 1.80. This is a very positive value and a sign of high solvency as it would only need 1.80 years to pay back of all of its debts.
AND has a Debt to FCF ratio of 1.80. This is amongst the best in the industry. AND outperforms 100.00% of its industry peers.
AND has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of AND (0.21) is better than 93.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 1.8 | ||
| Altman-Z | 5.91 |
ROIC/WACC1.48
WACC7.93%
2.3 Liquidity
A Current Ratio of 1.35 indicates that AND should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.35, AND belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
AND has a Quick Ratio of 1.30. This is a normal value and indicates that AND is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of AND (1.30) is better than 93.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.35 | ||
| Quick Ratio | 1.3 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 1.96% over the past year.
The Earnings Per Share has been growing by 14.82% on average over the past years. This is quite good.
The Revenue has been growing slightly by 0.34% in the past year.
AND shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.53% yearly.
EPS 1Y (TTM)1.96%
EPS 3Y-10.45%
EPS 5Y14.82%
EPS Q2Q%-10.53%
Revenue 1Y (TTM)0.34%
Revenue growth 3Y13.91%
Revenue growth 5Y17.53%
Sales Q2Q%-3%
3.2 Future
The Earnings Per Share is expected to grow by 9.16% on average over the next years. This is quite good.
The Revenue is expected to grow by 2.09% on average over the next years.
EPS Next Y7.39%
EPS Next 2Y10.57%
EPS Next 3Y9.16%
EPS Next 5YN/A
Revenue Next Year0.27%
Revenue Next 2Y1.98%
Revenue Next 3Y2.09%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 33.78, the valuation of AND can be described as expensive.
Based on the Price/Earnings ratio, AND is valued a bit cheaper than 73.33% of the companies in the same industry.
AND's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.86.
AND is valuated quite expensively with a Price/Forward Earnings ratio of 27.28.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AND indicates a somewhat cheap valuation: AND is cheaper than 73.33% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.29, AND is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.78 | ||
| Fwd PE | 27.28 |
4.2 Price Multiples
73.33% of the companies in the same industry are more expensive than AND, based on the Enterprise Value to EBITDA ratio.
AND's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.79 | ||
| EV/EBITDA | 13.48 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
AND has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)4.57
PEG (5Y)2.28
EPS Next 2Y10.57%
EPS Next 3Y9.16%
5. Dividend
5.1 Amount
AND has a yearly dividend return of 0.90%, which is pretty low.
AND's Dividend Yield is a higher than the industry average which is at 3.27.
With a Dividend Yield of 0.90, AND pays less dividend than the S&P500 average, which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.9% |
5.2 History
The dividend of AND decreases each year by -34.89%.
AND has been paying a dividend for over 5 years, so it has already some track record.
AND has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-34.89%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
26.73% of the earnings are spent on dividend by AND. This is a low number and sustainable payout ratio.
DP26.73%
EPS Next 2Y10.57%
EPS Next 3Y9.16%
TSX:AND (10/1/2025, 7:00:00 PM)
52.7
-0.07 (-0.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners76.5%
Inst Owner ChangeN/A
Ins Owners2.53%
Ins Owner ChangeN/A
Market Cap2.06B
Analysts50
Price Target56.92 (8.01%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.9% |
Yearly Dividend0.42
Dividend Growth(5Y)-34.89%
DP26.73%
Div Incr Years3
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-15.25%
Min EPS beat(2)-19.85%
Max EPS beat(2)-10.65%
EPS beat(4)0
Avg EPS beat(4)-9.2%
Min EPS beat(4)-19.85%
Max EPS beat(4)-0.99%
EPS beat(8)1
Avg EPS beat(8)-8.84%
EPS beat(12)3
Avg EPS beat(12)-6.41%
EPS beat(16)5
Avg EPS beat(16)11.49%
Revenue beat(2)0
Avg Revenue beat(2)-4.56%
Min Revenue beat(2)-7.25%
Max Revenue beat(2)-1.87%
Revenue beat(4)0
Avg Revenue beat(4)-3.59%
Min Revenue beat(4)-7.25%
Max Revenue beat(4)-1.87%
Revenue beat(8)1
Avg Revenue beat(8)-3.17%
Revenue beat(12)4
Avg Revenue beat(12)-1.94%
Revenue beat(16)7
Avg Revenue beat(16)0.32%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.3%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.54%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.78 | ||
| Fwd PE | 27.28 | ||
| P/S | 3.17 | ||
| P/FCF | 20.79 | ||
| P/OCF | 16.86 | ||
| P/B | 4.69 | ||
| P/tB | 16.33 | ||
| EV/EBITDA | 13.48 |
EPS(TTM)1.56
EY2.96%
EPS(NY)1.93
Fwd EY3.67%
FCF(TTM)2.53
FCFY4.81%
OCF(TTM)3.13
OCFY5.93%
SpS16.62
BVpS11.23
TBVpS3.23
PEG (NY)4.57
PEG (5Y)2.28
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.81% | ||
| ROE | 15.35% | ||
| ROCE | 16.09% | ||
| ROIC | 11.76% | ||
| ROICexc | 13.13% | ||
| ROICexgc | 34.45% | ||
| OM | 13.99% | ||
| PM (TTM) | 10.37% | ||
| GM | 33.85% | ||
| FCFM | 15.25% |
ROA(3y)9.88%
ROA(5y)11.71%
ROE(3y)15.44%
ROE(5y)22.37%
ROIC(3y)11.97%
ROIC(5y)12.76%
ROICexc(3y)12.48%
ROICexc(5y)13.78%
ROICexgc(3y)30.54%
ROICexgc(5y)29.2%
ROCE(3y)16.39%
ROCE(5y)17.47%
ROICexcg growth 3Y-1.36%
ROICexcg growth 5Y-1.14%
ROICexc growth 3Y4.48%
ROICexc growth 5Y-13.43%
OM growth 3Y-4.81%
OM growth 5Y-1.42%
PM growth 3Y-21.44%
PM growth 5Y-0.72%
GM growth 3Y-14.76%
GM growth 5Y-10.42%
F-Score5
Asset Turnover0.95
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 1.8 | ||
| Debt/EBITDA | 0.56 | ||
| Cap/Depr | 32.65% | ||
| Cap/Sales | 3.56% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 75.6% | ||
| Profit Quality | 147.02% | ||
| Current Ratio | 1.35 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 5.91 |
F-Score5
WACC7.93%
ROIC/WACC1.48
Cap/Depr(3y)36.55%
Cap/Depr(5y)30.34%
Cap/Sales(3y)3.8%
Cap/Sales(5y)3.06%
Profit Quality(3y)141.22%
Profit Quality(5y)125.45%
High Growth Momentum
Growth
EPS 1Y (TTM)1.96%
EPS 3Y-10.45%
EPS 5Y14.82%
EPS Q2Q%-10.53%
EPS Next Y7.39%
EPS Next 2Y10.57%
EPS Next 3Y9.16%
EPS Next 5YN/A
Revenue 1Y (TTM)0.34%
Revenue growth 3Y13.91%
Revenue growth 5Y17.53%
Sales Q2Q%-3%
Revenue Next Year0.27%
Revenue Next 2Y1.98%
Revenue Next 3Y2.09%
Revenue Next 5YN/A
EBIT growth 1Y-1.92%
EBIT growth 3Y8.43%
EBIT growth 5Y15.86%
EBIT Next Year74.49%
EBIT Next 3Y25.3%
EBIT Next 5YN/A
FCF growth 1Y6.06%
FCF growth 3Y11.81%
FCF growth 5Y13.66%
OCF growth 1Y-1.91%
OCF growth 3Y13.94%
OCF growth 5Y15.32%